These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6883739)

  • 1. Prevalence of salt-losing among congenital adrenal hyperplasia patients.
    Fife D; Rappaport EB
    Clin Endocrinol (Oxf); 1983 Aug; 19(2):259-64. PubMed ID: 6883739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should we monitor more closely the dosage of 9 alpha-fluorohydrocortisone in salt-losing congenital adrenal hyperplasia?
    Lopes LA; Dubuis JM; Vallotton MB; Sizonenko PC
    J Pediatr Endocrinol Metab; 1998; 11(6):733-7. PubMed ID: 9829228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varying expression for salt losing in related patients with congenital adrenal hyperplasia.
    Rosenbloom AL; Smith DW
    Pediatrics; 1966 Aug; 38(2):215-9. PubMed ID: 5944156
    [No Abstract]   [Full Text] [Related]  

  • 4. Sodium Chloride Supplementation Is Not Routinely Performed in the Majority of German and Austrian Infants with Classic Salt-Wasting Congenital Adrenal Hyperplasia and Has No Effect on Linear Growth and Hydrocortisone or Fludrocortisone Dose.
    Bonfig W; Roehl F; Riedl S; Brämswig J; Richter-Unruh A; Fricke-Otto S; Hübner A; Bettendorf M; Schönau E; Dörr H; Holl RW; Mohnike K
    Horm Res Paediatr; 2018; 89(1):7-12. PubMed ID: 29073619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency.
    Mullis PE; Hindmarsh PC; Brook CG
    Eur J Pediatr; 1990 Nov; 150(1):22-5. PubMed ID: 2079072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital adrenal hyperplasia--a clinical and genetic survey. Are we detecting male salt-losers?
    Murtaza L; Sibert JR; Hughes I; Balfour IC
    Arch Dis Child; 1980 Aug; 55(8):622-5. PubMed ID: 6969062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of breast feeding on the clinical features of salt-losing congenital adrenal hyperplasia.
    Curtis JA; Bailey JD
    Arch Dis Child; 1983 Jan; 58(1):71-3. PubMed ID: 6830279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone hypersecretion in "non-salt-losing" congenital adrenal hyperplasia.
    Bartter FC; Henkin RI; Bryan GT
    J Clin Invest; 1968 Aug; 47(8):1742-52. PubMed ID: 4299011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The frequency of congenital adrenal hyperplasia (cah) in Munich (author's transl)].
    Mauthe I; Laspe Knorr D
    Klin Padiatr; 1977 Mar; 189(2):172-6. PubMed ID: 558473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of 52 cases of 21-hydroxylase-deficient congenital adrenal hyperplasia].
    Yang Y; Zhou XY; Zhou XG
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):613-7. PubMed ID: 26108325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency.
    Donaldson MD; Thomas PH; Love JG; Murray GD; McNinch AW; Savage DC
    Arch Dis Child; 1994 Mar; 70(3):214-8. PubMed ID: 8135566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salt losing congenital adrenal hyperplasia.
    Churesigaew S
    J Med Assoc Thai; 1984 Jan; 67(1):24-30. PubMed ID: 6609221
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccine tolerance in steroid substituted patients with congenital adrenal hyperplasia.
    Weiss M; Dörr HG; Brandmaier R; Schwarz HP; Belohradsky BH
    Eur J Med Res; 1997 Jul; 2(7):290-2. PubMed ID: 9233902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salt-wasting 21-hydroxylase deficiency congenital adrenal hyperplasia and pyloric stenosis in two Hispanic brothers.
    Pitukcheewanont P; Nimkarn S; Austin J; Sack Z; Fisher LK
    J Pediatr; 2006 Aug; 149(2):268-70. PubMed ID: 16887450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiopathology of the salt-losing syndrome during congenital adrenal hyperplasia related to a 21-hydroxylation defect].
    Rappaport R
    Ann Pediatr (Paris); 1965 Dec; 12(12):807-8. PubMed ID: 5854043
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of the dose of oral hydrocortisone on growth rate during long-term treatment of children with salt losing congenital adrenal hyperplasia.
    Ciaccio M; Montiveros C; Rivarola MA; Belgorosky A
    Medicina (B Aires); 2002; 62(6):551-4. PubMed ID: 12532689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A female pseudohermaphrodite with salt losing congenital adrenal hyperplasia as the result of 21--beta--OH deficiency.
    Preeyasombat C; Siripoonya P; Tejavej A; Pitchayayothin N
    J Med Assoc Thai; 1975 Mar; 58(3):61-9. PubMed ID: 1127377
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal regulation of fluid, electrolyte, and acid-base homeostasis in the salt-losing syndrome of congenital adrenal hyperplasia (SL-CAH). ECF volume: a compensating factor in aldosterone deficiency.
    Oetliker OH; Zurbrügg RP
    J Clin Endocrinol Metab; 1978 Apr; 46(4):543-51. PubMed ID: 39083
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma renin activity and aldosterone concentration in normal subjects and patients with salt-losing type of congenital adrenal hyperplasia during infancy.
    Koshimizu T
    Clin Endocrinol (Oxf); 1979 May; 10(5):515-22. PubMed ID: 225066
    [No Abstract]   [Full Text] [Related]  

  • 20. Salt Losing Variety of Congenital Adrenal Hyperplasia--A Case Report.
    Nahar N; Dey AC; Khan KA; Dey SK; Mannan MA; Shahidullah M
    Mymensingh Med J; 2016 Jan; 25(1):179-81. PubMed ID: 26931272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.